What’s Behind Synlait Milk Ltd (ASX:SM1) Share Price Gain Today?

Sonal Goyal

21 October 2026 12:46 PM AEDT

What’s Behind Synlait Milk Ltd (ASX:SM1) Share Price Gain Today?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Synlait Milk Ltd (ASX:SM1) shares closed at $0.39 on 21 October 2026, up 9.86%.
Synlait appointed Leon Fung as permanent Chief Executive Officer on 21 October 2026.
Mr Fung was Acting CEO from 14 May 2026 and has been a Director since June 2024.

Synlait Milk Limited (ASX:SM1) shares rose 9.86% to close at $0.39 in the trading session on 21 October 2026, while the S&P/ASX 200 (XJO) stood at 8,809.20, down 7.70 points or 0.087%. Synlait is a dairy processor headquartered in Canterbury, New Zealand, listed on both the NZX (SML) and the ASX.

What Synlait Milk does

Synlait Milk is a New Zealand dairy company operating in the dairy and nutrition sectors. Its registered address is in Rakaia, Canterbury, and its shares are quoted on the NZX under the code SML and on the ASX under SM1.

The company’s Chair has referred to a recovery roadmap that Synlait is executing, and the latest announcement links the CEO appointment to continuity as that roadmap continues.

Permanent CEO appointment

On 21 October 2026, Synlait announced that it had appointed Leon Fung as its Chief Executive Officer. Amid today’s share price gain, this update gains attention. Mr Fung was appointed Acting CEO on 14 May 2026 and has served as a Director of Synlait since June 2024. The permanent appointment process was assisted by global consultancy Korn Ferry.

Synlait described Mr Fung as having nearly 30 years of experience across production, operations, capital engineering investments and market development in the dairy and nutrition sectors, with a track record of scaling operations, optimising supply chains and building teams across Asia-Pacific markets.

The Acting CEO period ran from 14 May 2026 to the permanent appointment on 21 October 2026, a little over five months. Mr Fung’s Director role on the Board since June 2024 means he has been involved with the company’s governance for more than two years.

Board commentary on the appointment

Chair George Adams said that since being appointed Acting CEO, Mr Fung had demonstrated leadership and commercial discipline with deep knowledge of dairy processing, which the company said helped deliver operational stability. The appointment was described as providing continuity, clarity and momentum as Synlait continues to execute its recovery roadmap.

Mr Fung said his time on the Board gave him an understanding of Synlait’s role in New Zealand’s dairy sector and that five months as Acting CEO had given him greater confidence in the company’s future, and he referred to navigating challenges and capitalising on opportunities ahead.

What the announcement does not cover

The announcement is limited to the appointment. It does not include remuneration terms, financial results, guidance or details of the recovery roadmap’s targets and timetable.

Sector context

Dairy processors in New Zealand source milk from farms across the country’s dairy regions and convert it into products such as ingredients and nutritional products for domestic and export customers. Earnings in the sector are linked to milk supply and pricing, processing costs, export demand and currency movements. A permanent chief executive after an interim period is a governance change that is routinely disclosed to the market.

New Zealand dairy company earnings are generally linked to global dairy prices, the cost of raw milk, processing efficiency and the New Zealand dollar, and processors often report on volumes and margins across ingredient and nutritional product categories. Because Synlait is listed on both the NZX and the ASX, its announcements are made to both exchanges at the same time.

Risks and uncertainties

Synlait’s own description of a recovery roadmap indicates that the company is in a recovery phase, and the outcome of that plan has not been described in the announcement. Leadership changes can bring strategic or operational shifts, and the company’s operating performance remains exposed to dairy market conditions, customer relationships and costs. The shares are priced at $0.39 and can be volatile. A single-day gain does not indicate the direction of future price movements.

What’s next

Synlait has stated that it will continue to execute its recovery roadmap under Mr Fung’s leadership. Further information on operations and financial performance is expected to be provided through its NZX and ASX announcements. Media enquiries are directed to Jo Scott, Head of Corporate Affairs and Engagement.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.